Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2009 entries
Sorted by: Best Match Show Resources per page
miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.

Cell cycle (Georgetown, Tex.)

Yang H, Lin J, Jiang J, Ji J, Wang C, Zhang J.
PMID: 33044899
Cell Cycle. 2020 Nov;19(21):2939-2954. doi: 10.1080/15384101.2020.1829824. Epub 2020 Oct 12.

MicroRNA functions as an oncogenic regulator or tumor suppressor in various human tumors. Although bioinformatics analysis suggested that miRNA-20b-5p may be associated with the tumorigenesis, its role in colon cancer remains elusive. To investigate the role of miRNA-20b-5p, HCT116...

Cite
Yang H, Lin J, Jiang J, et al. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Cell Cycle. 2020;19(21):2939-2954doi: 10.1080/15384101.2020.1829824.
Yang, H., Lin, J., Jiang, J., Ji, J., Wang, C., & Zhang, J. (2020). miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Cell cycle (Georgetown, Tex.), 19(21), 2939-2954. https://doi.org/10.1080/15384101.2020.1829824
Yang, Hui, et al. "miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer." Cell cycle (Georgetown, Tex.) vol. 19,21 (2020): 2939-2954. doi: https://doi.org/10.1080/15384101.2020.1829824
Yang H, Lin J, Jiang J, Ji J, Wang C, Zhang J. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Cell Cycle. 2020 Nov;19(21):2939-2954. doi: 10.1080/15384101.2020.1829824. Epub 2020 Oct 12. PMID: 33044899; PMCID: PMC7714476.
Copy Download .nbib Format: NLM
Mitochondrial stress delays tumorigenesis in a Li-Fraumeni syndrome mouse model.

Cell stress

Donnelly MP, Li J, Hwang PM.
PMID: 31225506
Cell Stress. 2019 Mar 21;3(4):115-117. doi: 10.15698/cst2019.04.182.

No abstract available.

Cite
Donnelly MP, Li J, Hwang PM. Mitochondrial stress delays tumorigenesis in a Li-Fraumeni syndrome mouse model. Cell Stress. 2019;3(4):115-117doi: 10.15698/cst2019.04.182.
Donnelly, M. P., Li, J., & Hwang, P. M. (2019). Mitochondrial stress delays tumorigenesis in a Li-Fraumeni syndrome mouse model. Cell stress, 3(4), 115-117. https://doi.org/10.15698/cst2019.04.182
Donnelly, Matthew P, et al. "Mitochondrial stress delays tumorigenesis in a Li-Fraumeni syndrome mouse model." Cell stress vol. 3,4 (2019): 115-117. doi: https://doi.org/10.15698/cst2019.04.182
Donnelly MP, Li J, Hwang PM. Mitochondrial stress delays tumorigenesis in a Li-Fraumeni syndrome mouse model. Cell Stress. 2019 Mar 21;3(4):115-117. doi: 10.15698/cst2019.04.182. PMID: 31225506; PMCID: PMC6551832.
Copy Download .nbib Format: NLM
Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family.

European journal of medical genetics

Radmanesh H, Liu D, Geffers R, Shandiz FH, Sadr-Nabavi A, Hillemanns P, Park-Simon TW, Dörk T.
PMID: 35032689
Eur J Med Genet. 2022 Jan 12;104425. doi: 10.1016/j.ejmg.2022.104425. Epub 2022 Jan 12.

Breast cancer is the most frequent malignancy among women in both developed and developing countries. Although several genes have been identified to harbor germline variants contributing to breast cancer risk, much of the heritability for breast cancer is yet...

Cite
Radmanesh H, Liu D, Geffers R, et al. Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family. Eur J Med Genet. 2022;104425doi: 10.1016/j.ejmg.2022.104425.
Radmanesh, H., Liu, D., Geffers, R., Shandiz, F. H., Sadr-Nabavi, A., Hillemanns, P., Park-Simon, T. W., & Dörk, T. (2022). Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family. European journal of medical genetics, 104425. https://doi.org/10.1016/j.ejmg.2022.104425
Radmanesh, Hoda, et al. "Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family." European journal of medical genetics vol. (2022): 104425. doi: https://doi.org/10.1016/j.ejmg.2022.104425
Radmanesh H, Liu D, Geffers R, Shandiz FH, Sadr-Nabavi A, Hillemanns P, Park-Simon TW, Dörk T. Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family. Eur J Med Genet. 2022 Jan 12;104425. doi: 10.1016/j.ejmg.2022.104425. Epub 2022 Jan 12. PMID: 35032689.
Copy Download .nbib Format: NLM
Sequential acral lentiginous melanomas of the foot.

Case reports in dermatology

Uehara J, Ito Y, Takahashi I, Honma M, Ishida-Yamamoto A, Matsuo S, Iizuka H.
PMID: 21537371
Case Rep Dermatol. 2010 Dec 22;2(3):201-6. doi: 10.1159/000323467.

A 64-year-old Japanese woman had a lightly brown-blackish pigmented macule (1.2 cm in diameter) on the left sole of her foot. She received surgical excision following a diagnosis of acral lentiginous melanoma (ALM), which was confirmed histopathologically. One month...

Cite
Uehara J, Ito Y, Takahashi I, et al. Sequential acral lentiginous melanomas of the foot. Case Rep Dermatol. 2010;2(3):201-6doi: 10.1159/000323467.
Uehara, J., Ito, Y., Takahashi, I., Honma, M., Ishida-Yamamoto, A., Matsuo, S., & Iizuka, H. (2010). Sequential acral lentiginous melanomas of the foot. Case reports in dermatology, 2(3), 201-6. https://doi.org/10.1159/000323467
Uehara, Jiro, et al. "Sequential acral lentiginous melanomas of the foot." Case reports in dermatology vol. 2,3 (2010): 201-6. doi: https://doi.org/10.1159/000323467
Uehara J, Ito Y, Takahashi I, Honma M, Ishida-Yamamoto A, Matsuo S, Iizuka H. Sequential acral lentiginous melanomas of the foot. Case Rep Dermatol. 2010 Dec 22;2(3):201-6. doi: 10.1159/000323467. PMID: 21537371; PMCID: PMC3085035.
Copy Download .nbib Format: NLM
HPV-p53-miR-34a axis in HPV-associated cancers.

Annals of translational medicine

Chen J, Zhao KN.
PMID: 26734641
Ann Transl Med. 2015 Dec;3(21):331. doi: 10.3978/j.issn.2305-5839.2015.09.39.

Human papillomaviruses (HPVs) are known to cause many cancers by altering multiple signalling pathways through their oncogene integration into host genome and expression. Studies have shown that many microRNAs (miRs) may function as oncogenes (called as oncomiRs) to promote...

Cite
Chen J, Zhao KN. HPV-p53-miR-34a axis in HPV-associated cancers. Ann Transl Med. 2015;3(21):331doi: 10.3978/j.issn.2305-5839.2015.09.39.
Chen, J., & Zhao, K. N. (2015). HPV-p53-miR-34a axis in HPV-associated cancers. Annals of translational medicine, 3(21), 331. https://doi.org/10.3978/j.issn.2305-5839.2015.09.39
Chen, Jiezhong, and Zhao, Kong-Nan. "HPV-p53-miR-34a axis in HPV-associated cancers." Annals of translational medicine vol. 3,21 (2015): 331. doi: https://doi.org/10.3978/j.issn.2305-5839.2015.09.39
Chen J, Zhao KN. HPV-p53-miR-34a axis in HPV-associated cancers. Ann Transl Med. 2015 Dec;3(21):331. doi: 10.3978/j.issn.2305-5839.2015.09.39. PMID: 26734641; PMCID: PMC4691011.
Copy Download .nbib Format: NLM
miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth.

Oncotarget

Egan SM, Karasik E, Ellis L, Gollnick SO.
PMID: 28978058
Oncotarget. 2017 Jun 28;8(40):67626-67638. doi: 10.18632/oncotarget.18795. eCollection 2017 Sep 15.

According to the CDC prostate cancer (CaP) has the highest incidence and second highest mortality rate amongst cancers in American men. Constitutive NF-κB activation is a hallmark of CaP and this pathway drives many pro-tumorigenic characteristics of CaP cells,...

Cite
Egan SM, Karasik E, Ellis L, et al. miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth. Oncotarget. 2017;8(40):67626-67638doi: 10.18632/oncotarget.18795.
Egan, S. M., Karasik, E., Ellis, L., & Gollnick, S. O. (2017). miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth. Oncotarget, 8(40), 67626-67638. https://doi.org/10.18632/oncotarget.18795
Egan, Shawn M, et al. "miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth." Oncotarget vol. 8,40 (2017): 67626-67638. doi: https://doi.org/10.18632/oncotarget.18795
Egan SM, Karasik E, Ellis L, Gollnick SO. miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth. Oncotarget. 2017 Jun 28;8(40):67626-67638. doi: 10.18632/oncotarget.18795. eCollection 2017 Sep 15. PMID: 28978058; PMCID: PMC5620198.
Copy Download .nbib Format: NLM
Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats.

Experimental and therapeutic medicine

Gao X, Fan L, Li H, Li J, Liu X, Sun R, Yu Z.
PMID: 26893626
Exp Ther Med. 2016 Feb;11(2):427-434. doi: 10.3892/etm.2015.2931. Epub 2015 Dec 11.

Hyperammonemia is considered to be central to the pathophysiology of hepatic encephalopathy in patients exhibiting hepatic failure (HF). It has previously been determined that hyperammonemia is a serious metabolic disorder commonly observed in patients with HF. However, it is...

Cite
Gao X, Fan L, Li H, et al. Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats. Exp Ther Med. 2015;11(2):427-434doi: 10.3892/etm.2015.2931.
Gao, X., Fan, L., Li, H., Li, J., Liu, X., Sun, R., & Yu, Z. (2016). Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats. Experimental and therapeutic medicine, 11(2), 427-434. https://doi.org/10.3892/etm.2015.2931
Gao, Xiaojuan, et al. "Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats." Experimental and therapeutic medicine vol. 11,2 (2016): 427-434. doi: https://doi.org/10.3892/etm.2015.2931
Gao X, Fan L, Li H, Li J, Liu X, Sun R, Yu Z. Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats. Exp Ther Med. 2016 Feb;11(2):427-434. doi: 10.3892/etm.2015.2931. Epub 2015 Dec 11. PMID: 26893626; PMCID: PMC4733954.
Copy Download .nbib Format: NLM
Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells.

Biomolecules & therapeutics

Liu Q, Cao Y, Zhou P, Gui S, Wu X, Xia Y, Tu J.
PMID: 29301388
Biomol Ther (Seoul). 2018 May 01;26(3):328-334. doi: 10.4062/biomolther.2017.042.

Because of the unsatisfactory treatment options for breast cancer (BC), there is a need to develop novel therapeutic approaches for this malignancy. One such strategy is chemotherapy using non-toxic dietary substances and botanical products. Studies have shown that Panduratin...

Cite
Liu Q, Cao Y, Zhou P, et al. Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells. Biomol Ther (Seoul). 2018;26(3):328-334doi: 10.4062/biomolther.2017.042.
Liu, Q., Cao, Y., Zhou, P., Gui, S., Wu, X., Xia, Y., & Tu, J. (2018). Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells. Biomolecules & therapeutics, 26(3), 328-334. https://doi.org/10.4062/biomolther.2017.042
Liu, Qiuming, et al. "Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells." Biomolecules & therapeutics vol. 26,3 (2018): 328-334. doi: https://doi.org/10.4062/biomolther.2017.042
Liu Q, Cao Y, Zhou P, Gui S, Wu X, Xia Y, Tu J. Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells. Biomol Ther (Seoul). 2018 May 01;26(3):328-334. doi: 10.4062/biomolther.2017.042. PMID: 29301388; PMCID: PMC5933901.
Copy Download .nbib Format: NLM
The Cell Cycle Regulators .

Cancer genomics & proteomics

El-Salahy E, Abou-Ghalia AH, Adli A, Kassim SK.
PMID: 31394712
Cancer Genomics Proteomics. 2005 Jul-Aug;2(4):239-245. Epub 2005 Jul 01.

Laryngeal squamous cell carcinoma (LSCC) is a frequent malignancy with a complex and undefined etiology to date. The recently identified cyclin-dependent kinase inhibitor p15

Cite
El-Salahy E, Abou-Ghalia AH, Adli A, et al. The Cell Cycle Regulators . Cancer Genomics Proteomics. 2005;2(4):239-245
El-Salahy, E., Abou-Ghalia, A. H., Adli, A., & Kassim, S. K. (2005). The Cell Cycle Regulators . Cancer genomics & proteomics, 2(4), 239-245.
El-Salahy, Eman, et al. "The Cell Cycle Regulators ." Cancer genomics & proteomics vol. 2,4 (2005): 239-245.
El-Salahy E, Abou-Ghalia AH, Adli A, Kassim SK. The Cell Cycle Regulators . Cancer Genomics Proteomics. 2005 Jul-Aug;2(4):239-245. Epub 2005 Jul 01. PMID: 31394712.
Copy Download .nbib Format: NLM
Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest.

OncoTargets and therapy

Yang L, Liu H, Long M, Wang X, Lin F, Gao Z, Zhang H.
PMID: 29750041
Onco Targets Ther. 2018 Apr 30;11:2409-2417. doi: 10.2147/OTT.S154337. eCollection 2018.

BACKGROUND: Targeted therapies have been proven as promising in the treatment of breast cancer and have improved survival and quality of life in advanced breast cancer. We previously identified a novel peptide SA12 which showed significant activity in the...

Cite
Yang L, Liu H, Long M, et al. Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest. Onco Targets Ther. 2018;11:2409-2417doi: 10.2147/OTT.S154337.
Yang, L., Liu, H., Long, M., Wang, X., Lin, F., Gao, Z., & Zhang, H. (2018). Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest. OncoTargets and therapy, 112409-2417. https://doi.org/10.2147/OTT.S154337
Yang, Longfei, et al. "Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest." OncoTargets and therapy vol. 11 (2018): 2409-2417. doi: https://doi.org/10.2147/OTT.S154337
Yang L, Liu H, Long M, Wang X, Lin F, Gao Z, Zhang H. Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest. Onco Targets Ther. 2018 Apr 30;11:2409-2417. doi: 10.2147/OTT.S154337. eCollection 2018. PMID: 29750041; PMCID: PMC5935185.
Copy Download .nbib Format: NLM
Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment.

Clinical case reports

Perri F, Longo F, Della Vittoria Scarpati G, Pisconti S, Longo V, Addeo R, Carducci F, Buonerba C, Fulciniti F, Solla R.
PMID: 29375838
Clin Case Rep. 2017 Nov 24;6(1):56-62. doi: 10.1002/ccr3.1107. eCollection 2018 Jan.

Pretherapy assessment has a crucial role in the management of advanced oropharyngeal carcinoma. The case report represents an example of how translational research may help to optimize the therapeutic options and to choose a well-shaped therapy adapted to the...

Cite
Perri F, Longo F, Della Vittoria Scarpati G, et al. Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment. Clin Case Rep. 2017;6(1):56-62doi: 10.1002/ccr3.1107.
Perri, F., Longo, F., Della Vittoria Scarpati, G., Pisconti, S., Longo, V., Addeo, R., Carducci, F., Buonerba, C., Fulciniti, F., & Solla, R. (2018). Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment. Clinical case reports, 6(1), 56-62. https://doi.org/10.1002/ccr3.1107
Perri, Francesco, et al. "Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment." Clinical case reports vol. 6,1 (2018): 56-62. doi: https://doi.org/10.1002/ccr3.1107
Perri F, Longo F, Della Vittoria Scarpati G, Pisconti S, Longo V, Addeo R, Carducci F, Buonerba C, Fulciniti F, Solla R. Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment. Clin Case Rep. 2017 Nov 24;6(1):56-62. doi: 10.1002/ccr3.1107. eCollection 2018 Jan. PMID: 29375838; PMCID: PMC5771910.
Copy Download .nbib Format: NLM
Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation.

Frontiers in cellular neuroscience

Zhou L, Chen D, Huang XM, Long F, Cai H, Yao WX, Chen ZC, Liao ZJ, Deng ZZ, Tan S, Shan YL, Cai W, Wang YG, Yang RH, Jiang N, Peng T, Hong MF, Lu ZQ.
PMID: 29033786
Front Cell Neurosci. 2017 Sep 29;11:281. doi: 10.3389/fncel.2017.00281. eCollection 2017.

β-Amyloid protein (Aβ) is thought to cause neuronal loss in Alzheimer's disease (AD). Aβ treatment promotes the re-activation of a mitotic cycle and induces rapid apoptotic death of neurons. However, the signaling pathways mediating cell-cycle activation during neuron apoptosis...

Cite
Zhou L, Chen D, Huang XM, et al. Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation. Front Cell Neurosci. 2017;11:281doi: 10.3389/fncel.2017.00281.
Zhou, L., Chen, D., Huang, X. M., Long, F., Cai, H., Yao, W. X., Chen, Z. C., Liao, Z. J., Deng, Z. Z., Tan, S., Shan, Y. L., Cai, W., Wang, Y. G., Yang, R. H., Jiang, N., Peng, T., Hong, M. F., & Lu, Z. Q. (2017). Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation. Frontiers in cellular neuroscience, 11281. https://doi.org/10.3389/fncel.2017.00281
Zhou, Li, et al. "Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation." Frontiers in cellular neuroscience vol. 11 (2017): 281. doi: https://doi.org/10.3389/fncel.2017.00281
Zhou L, Chen D, Huang XM, Long F, Cai H, Yao WX, Chen ZC, Liao ZJ, Deng ZZ, Tan S, Shan YL, Cai W, Wang YG, Yang RH, Jiang N, Peng T, Hong MF, Lu ZQ. Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation. Front Cell Neurosci. 2017 Sep 29;11:281. doi: 10.3389/fncel.2017.00281. eCollection 2017. PMID: 29033786; PMCID: PMC5626855.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2009 entries